Clinical trial

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

NCT06321640

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

GENETIC · Unmapped registry intervention Cohort A: primarily operable disease, candidate to adjuvant Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention Cohort B: locally advanced disease Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention Cohort C: metastatic disease Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention Cohort D: Progressive disease Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention Cohort E: Hematological neoplasms Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention Cohort F: Toxicity Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-07-08

PhaseN/A

Conditions

Breast Cancerverified · MONDO: breast cancer

Lung Cancerverified · MONDO: lung cancer

Melanomaverified · MONDO: melanoma

Head and Neck Cancerverified · MONDO: head and neck cancer

Urothelial Carcinomaverified · MONDO: urothelial carcinoma

Colorectal Cancerverified · MONDO: colorectal cancer

Liver Metastasesunresolved

Lung Metastasesunresolved

Interventions

Cohort A: primarily operable disease, candidate to adjuvantGENETIC

Cohort B: locally advanced diseaseGENETIC

Cohort C: metastatic diseaseGENETIC

Cohort D: Progressive diseaseGENETIC

Cohort E: Hematological neoplasmsGENETIC

Cohort F: ToxicityGENETIC

Sponsors & collaborators

European Institute of Oncologylead sponsor

Mapped research locations

MilanItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06321640 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.